Skip to main content

Epidemiology of Pediatric Respiratory Syncytial Virus-Associated Illness in FDA’s Sentinel System

    Basic Details
    Date Posted
    Health Outcome(s)
    respiratory syncytial virus (RSV)
    respiratory syncytial virus-associated illness

    FDA’s Sentinel System was used to characterize the epidemiology of respiratory syncytial virus-associated illness (RSV-AI) in U.S. children between 1 month and 5 years of age from January 2008 through June 2016. Greater than 80% of cases were managed as outpatients and >50% of hospitalized children, including those requiring intensive care, had no traditional risk factors besides young chronologic age. 

    Additional Details
    FDA Center
    Time Period
    January 1, 2008 - June 30, 2016
    Analysis Type
    Population / Cohort
    Children 1 month to 5 years of age
    Data Sources
    Sentinel Distributed Database (SDD)